TY  - JOUR
T1  - ADverse events and quadrivalent human papillomavirus recombinant vaccine
AU  - Debold V, Hurwitz E
Y1  - 2009/12/23
N1  - 10.1001/jama.2009.1880
JO  - JAMA
SP  - 2657
EP  - 2658
VL  - 302
IS  - 24
N2  - 
To the Editor: Dr Slade and colleagues1 evaluated reports submitted to the Vaccine Adverse Event Reporting System (VAERS) for quadrivalent human papillomavirus recombinant vaccine (qHPV). Federal officials have cited this study as evidence that qHPV “is a safe and effective vaccine.”2 However, we consider that conclusion to be unwarranted because the study draws inferences from data likely to be systematically biased, and because the design of the study cannot disprove causal associations at the individual level.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2009.1880
UR  - http://dx.doi.org/10.1001/jama.2009.1880
ER  -